First-in-human study of CPL’116 – a dual JAK/ROCK inhibitor – in healthy subjects
Agnieszka Gierczak‐Pachulska, Piotr Pankiewicz, Daniel Rabczenko, Paweł Żero et al.
Citations
1 citations
Journal
Frontiers in Pharmacology
Topics
Cytokine Signaling Pathways and Interactions
Field-Weighted Citation Impact (FWCI)
1.05
article
First-in-human study of CPL’116 – a dual JAK/ROCK inhibitor – in healthy subjects
Agnieszka Gierczak‐Pachulska, Piotr Pankiewicz, Daniel Rabczenko, Paweł Żero, Michał Kaza, Dorota Włodarczyk, Katarzyna Jarus‐Dziedzic, Martyna Banach, Beata M. Zygmunt, Maciej Wieczorek, Agnieszka Segiet, Piotr J. Rudzki, Cezary Piwowarczyk
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in PharmacologyVol. 16
Institutions
Institute of Physiology and Pathology of Hearing (PL), Celon Pharma (Poland) (PL)